Advances in Biology and Therapy of Multiple Myeloma Volume 2: Translational and Clinical Research /

Despite the advances in conventional, and novel agent and high dose chemotherapy, multiple myeloma remains incurable. In order to overcome resistance to current therapies and improve patient outcome, novel biologically-based treatment approaches are being developed. Current translational research in...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Munshi, Nikhil C. (Editor ), Anderson, Kenneth C. (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York, NY : Springer New York : Imprint: Springer, 2013.
Edición:1st ed. 2013.
Temas:
Cancer.
Pharmacology.
Cancer Biology.
Acceso en línea:Texto Completo
Tabla de Contenidos:
  • T cell responses in myeloma
  • Novel antigenic targets for immunotherapy in myeloma
  • Antibody-based therapies in Multiple Myeloma
  • Defining multiple myeloma as a target for DNA gene fusion vaccines
  • Harnessing allogeneic immunity for anti-myeloma response
  • Dendritic cell and peptide-based vaccination in myeloma
  • New Proteasome inhibitors
  • Newer Imids
  • New agents in myeloma
  • Early Combination Studies in MM
  • The effect of novel antimyeloma agents on bone metabolism
  • Index.

Ejemplares similares